Pro-dex Inc (PDEX)

$19.88

+0.35

(+1.79%)▲

Live

Insights on Pro-dex Inc

  • Increasing Revenue

    Revenue is up for the last 3 quarters, 10.63M → 14.29M (in $), with an average increase of 13.7% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, 500.0K → 655.0K (in $), with an average increase of 23.7% per quarter

  • Vs ISRG

    In the last 1 year, Intuitive Surgical, Inc. has given 29.4% return, outperforming this stock by 26.6%

  • Vs ISRG

    In the last 3 years, Intuitive Surgical, Inc. has given 45.7% return, outperforming this stock by 87.6%

Performance

  • $19.65
    $19.88
    $19.88
    downward going graph

    1.16%

    Downside

    Day's Volatility :1.16%

    Upside

    0.0%

    downward going graph
  • $14.51
    $22.99
    $19.88
    downward going graph

    27.01%

    Downside

    52 Weeks Volatility :36.89%

    Upside

    13.53%

    downward going graph

Returns

PeriodPro-dex IncIndex (Russel 2000)
3 Months
10.03%
0.0%
6 Months
20.18%
0.0%
1 Year
2.79%
0.0%
3 Years
-41.94%
-22.6%

Highlights

Market Capitalization
67.4M
Book Value
$8.96
Earnings Per Share (EPS)
0.57
PE Ratio
34.58
PEG Ratio
0.0
Wall Street Target Price
28.0
Profit Margin
4.13%
Operating Margin TTM
15.48%
Return On Assets TTM
8.24%
Return On Equity TTM
7.19%
Revenue TTM
49.5M
Revenue Per Share TTM
13.99
Quarterly Revenue Growth YOY
9.3%
Gross Profit TTM
12.7M
EBITDA
7.5M
Diluted Eps TTM
0.57
Quarterly Earnings Growth YOY
-0.58
EPS Estimate Current Year
0.5
EPS Estimate Next Year
1.38
EPS Estimate Current Quarter
0.35
EPS Estimate Next Quarter
0.36

Analyst Recommendation

Buy
    85%Buy
    14%Hold
    0
    0%Sell
Based on 7 Wall street analysts offering stock ratings for Pro-dex Inc(by analysts ranked 0 to 5 stars)
Based on 7 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
6
6
6
Hold
1
1
1
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 40.85%

Current $19.88
Target $28.00

Company Financials

FY18Y/Y Change
Revenue
22.5M
↑ 2.38%
Net Income
1.6M
↓ 68.12%
Net Profit Margin
7.22%
↓ 15.95%
FY19Y/Y Change
Revenue
27.2M
↑ 20.95%
Net Income
4.1M
↑ 155.89%
Net Profit Margin
15.27%
↑ 8.05%
FY20Y/Y Change
Revenue
34.8M
↑ 28.2%
Net Income
6.1M
↑ 47.35%
Net Profit Margin
17.55%
↑ 2.28%
FY21Y/Y Change
Revenue
38.0M
↑ 9.17%
Net Income
4.5M
↓ 27.19%
Net Profit Margin
11.7%
↓ 5.85%
FY22Y/Y Change
Revenue
42.0M
↑ 10.55%
Net Income
4.6M
↑ 2.74%
Net Profit Margin
10.88%
↓ 0.82%
FY23Y/Y Change
Revenue
46.1M
↑ 9.62%
Net Income
7.1M
↑ 54.72%
Net Profit Margin
15.35%
↑ 4.47%
Q4 FY22Q/Q Change
Revenue
11.3M
↑ 1.76%
Net Income
879.0K
↓ 18.31%
Net Profit Margin
7.79%
↓ 1.92%
Q1 FY23Q/Q Change
Revenue
13.1M
↑ 15.93%
Net Income
1.6M
↑ 83.96%
Net Profit Margin
12.36%
↑ 4.57%
Q2 FY23Q/Q Change
Revenue
10.6M
↓ 18.66%
Net Income
1.5M
↓ 7.17%
Net Profit Margin
14.11%
↑ 1.75%
Q3 FY23Q/Q Change
Revenue
10.6M
↑ 0.0%
Net Income
3.8M
↑ 153.56%
Net Profit Margin
35.77%
↑ 21.66%
Q4 FY23Q/Q Change
Revenue
12.6M
↑ 18.32%
Net Income
500.0K
↓ 86.86%
Net Profit Margin
3.97%
↓ 31.8%
Q1 FY24Q/Q Change
Revenue
14.3M
↑ 13.54%
Net Income
655.0K
↑ 31.0%
Net Profit Margin
4.58%
↑ 0.61%
FY18Y/Y Change
Total Assets
19.9M
↑ 21.81%
Total Liabilities
2.6M
↑ 0.0%
FY19Y/Y Change
Total Assets
25.5M
↑ 28.13%
Total Liabilities
8.5M
↑ 222.3%
FY20Y/Y Change
Total Assets
31.1M
↑ 21.97%
Total Liabilities
12.1M
↑ 41.73%
FY21Y/Y Change
Total Assets
40.3M
↑ 29.54%
Total Liabilities
20.2M
↑ 67.74%
FY22Y/Y Change
Total Assets
47.3M
↑ 17.38%
Total Liabilities
23.7M
↑ 16.91%
FY23Y/Y Change
Total Assets
51.8M
↑ 9.5%
Total Liabilities
20.2M
↓ 14.48%
Q4 FY22Q/Q Change
Total Assets
47.6M
↓ 0.8%
Total Liabilities
23.1M
↓ 1.89%
Q1 FY23Q/Q Change
Total Assets
47.0M
↓ 1.27%
Total Liabilities
21.1M
↓ 8.52%
Q2 FY23Q/Q Change
Total Assets
51.8M
↑ 10.32%
Total Liabilities
20.2M
↓ 4.27%
Q3 FY23Q/Q Change
Total Assets
51.8M
↑ 0.0%
Total Liabilities
20.2M
↑ 0.0%
Q4 FY23Q/Q Change
Total Assets
51.4M
↓ 0.76%
Total Liabilities
19.6M
↓ 2.93%
Q1 FY24Q/Q Change
Total Assets
50.5M
↓ 1.71%
Total Liabilities
19.6M
↓ 0.16%
FY18Y/Y Change
Operating Cash Flow
3.1M
↓ 4.3%
Investing Cash Flow
-4.1M
↑ 301.07%
Financing Cash Flow
2.0M
↓ 771.81%
FY19Y/Y Change
Operating Cash Flow
3.3M
↑ 7.43%
Investing Cash Flow
-1.2M
↓ 70.3%
Financing Cash Flow
450.0K
↓ 77.52%
FY20Y/Y Change
Operating Cash Flow
5.9M
↑ 77.3%
Investing Cash Flow
-2.3M
↑ 87.15%
Financing Cash Flow
-4.0M
↓ 984.22%
FY21Y/Y Change
Operating Cash Flow
-2.1M
↓ 135.24%
Investing Cash Flow
-3.7M
↑ 62.22%
Financing Cash Flow
3.1M
↓ 177.61%
FY22Y/Y Change
Operating Cash Flow
-847.0K
↓ 59.24%
Investing Cash Flow
-1.2M
↓ 66.71%
Financing Cash Flow
-790.0K
↓ 125.58%
FY23Y/Y Change
Operating Cash Flow
5.5M
↓ 744.86%
Investing Cash Flow
-885.0K
↓ 28.34%
Financing Cash Flow
-2.5M
↑ 215.19%
Q4 FY22Q/Q Change
Operating Cash Flow
-395.0K
↓ 113.66%
Investing Cash Flow
-508.0K
↑ 464.44%
Financing Cash Flow
-1.5M
↑ 77.37%
Q1 FY23Q/Q Change
Operating Cash Flow
2.3M
↓ 691.9%
Investing Cash Flow
-135.0K
↓ 73.43%
Financing Cash Flow
-497.0K
↓ 67.15%
Q2 FY23Q/Q Change
Operating Cash Flow
627.0K
↓ 73.18%
Investing Cash Flow
-152.0K
↑ 12.59%
Financing Cash Flow
373.0K
↓ 175.05%

Technicals Summary

Sell

Neutral

Buy

Pro-dex Inc is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Pro-dex Inc
Pro-dex Inc
9.84%
20.18%
2.79%
-41.94%
80.5%
Intuitive Surgical, Inc.
Intuitive Surgical, Inc.
5.43%
29.51%
27.2%
45.72%
155.38%
Resmed Inc.
Resmed Inc.
-4.4%
28.39%
-6.63%
1.01%
81.81%
Becton, Dickinson And Company
Becton, Dickinson And Company
0.96%
0.53%
-5.96%
-0.76%
1.54%
West Pharmaceutical Services Inc
West Pharmaceutical Services Inc
-10.32%
-6.31%
-4.27%
-1.41%
182.66%
Alcon Ag
Alcon Ag
11.48%
22.41%
13.04%
27.67%
52.06%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Pro-dex Inc
Pro-dex Inc
34.58
34.58
0.0
0.5
0.07
0.08
NA
8.96
Intuitive Surgical, Inc.
Intuitive Surgical, Inc.
72.45
72.45
7.13
6.29
0.16
0.08
NA
39.37
Resmed Inc.
Resmed Inc.
32.26
32.26
1.75
7.73
0.22
0.12
0.01
31.52
Becton, Dickinson And Company
Becton, Dickinson And Company
49.78
49.78
1.34
13.05
0.05
0.03
0.02
88.74
West Pharmaceutical Services Inc
West Pharmaceutical Services Inc
43.66
43.66
6.72
7.76
0.21
0.11
0.0
36.72
Alcon Ag
Alcon Ag
42.24
42.24
4.59
3.07
0.05
0.02
0.0
42.13
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Pro-dex Inc
Pro-dex Inc
Buy
$67.4M
80.5%
34.58
4.13%
Intuitive Surgical, Inc.
Intuitive Surgical, Inc.
Buy
$142.6B
155.38%
72.45
27.16%
Resmed Inc.
Resmed Inc.
Buy
$30.8B
81.81%
32.26
20.91%
Becton, Dickinson And Company
Becton, Dickinson And Company
Buy
$67.0B
1.54%
49.78
6.76%
West Pharmaceutical Services Inc
West Pharmaceutical Services Inc
Buy
$24.3B
182.66%
43.66
19.42%
Alcon Ag
Alcon Ag
Buy
$44.0B
52.06%
42.24
10.96%

Institutional Holdings

  • Vanguard Group Inc

    3.62%

  • Punch & Associates Inv Mgmt Inc

    2.21%

  • Dimensional Fund Advisors, Inc.

    1.75%

  • Acadian Asset Management LLC

    1.66%

  • BlackRock Inc

    1.40%

  • Northern Trust Corp

    0.76%

Company Information

for over 40 years pro-dex has successfully collaborated with several of the world’s largest providers of medical and dental devices. wherever you are in your process, we can help you. whether your product is partially or fully-designed, we have the capabilities to deliver the services you’re in need of. our staff is experienced in providing engineering, precision machining and fabrication, electro-mechanical assembly, components, sub-assemblies, finished products, and flexible volumes - all with exceptional service. as we’ve experienced growth at pro-dex, we’ve recognized the need to expand our engineering services division. we can offer you powerful solutions including consulting, varying engineering services, and staffing. we’re here to connect you with engineering support for the mechanical, electrical, and manufacturing needs of your company. while we may have built our business around the design and manufacturing for medical oem’s, we have since found increased success working wit

Organization
Pro-dex Inc
Employees
145
CEO
Mr. Richard Lee Van Kirk Jr.
Industry
Health Services

Discover More

FAQs